Tolerability of nintedanib in the elderly with idiopathic pulmonary fibrosis: A single-center retrospective study

Idiopathic pulmonary fibrosis (IPF), a fibrosing interstitial lung disease, predominantly affects the elderly and is associated with a high mortality risk. Nintedanib, a tyrosine kinase inhibitor, significantly reduces IPF progression. However, data on the tolerability and efficacy of nintedanib in...

Descripción completa

Detalles Bibliográficos
Autores principales: Komatsu, Masamichi, Yamamoto, Hiroshi, Ichiyama, Takashi, Kawakami, Satoshi, Uehara, Takeshi, Yoshikawa, Yumi, Kitaguchi, Yoshiaki, Ushiki, Atsuhito, Yasuo, Masanori, Hanaoka, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812933/
https://www.ncbi.nlm.nih.gov/pubmed/35113907
http://dx.doi.org/10.1371/journal.pone.0262795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812933/
https://www.ncbi.nlm.nih.gov/pubmed/35113907
http://dx.doi.org/10.1371/journal.pone.0262795

Ejemplares similares